StocksFin Logo
Abbott Laboratories country of incorporation
|
|
Mr. Robert Ford
|
113,000 employees
NYSE | Healthcare | Medical Devices
Novartis AG country of incorporation
|
|
Joseph Jimenez
|
108,000 employees
NYSE | Healthcare | Drug Manufacturers—General
Q322 reported Nov 1, 2022 Reporting Period
$10.41B -4.7% vs. Q321 Revenues Q322
55.53% -6.7% vs. Q321 Gross Profit Margin
13.78% -28.3% vs. Q321 Net Profit Margin
2.31B -14.4% vs. Q321 Free Cash Flow Q322
$1.15 -3.2% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.68%
Q322
Q322 reported Sep 30, 2022 Reporting Period
$12.84B -3.9% vs. Q321 Revenues Q322
70.36% -0.3% vs. Q321 Gross Profit Margin
12.25% -40.6% vs. Q321 Net Profit Margin
4.14B -16% vs. Q321 Free Cash Flow Q322
$0.73 -40.7% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.68%
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
1.22
0.99
Current Ratio
1.86
1.31
Cash Ratio
0.72
0.31
Price to Book
3.38
2.71
Price to Sales
11.6
12.83
Price to Earnings
21.03
26.18